Related Experiment Video
Updated: Jan 16, 2026
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Risk and determinants of mortality associated with invasive group A streptococcus (iGAS) disease in Scotland: A
Ebrahim Ghaderi1, Eisin McDonald1, Hazel Henderson1
1Respiratory Bacterial Pathogens Team, Public Health Scotland, Glasgow, Scotland.
Objectives:
Understanding determinants of mortality in invasive Group A Streptococcal (iGAS) infections is essential for developing targeted public health measures and improving clinical management. Using a comprehensive prospectively-collected national surveillance dataset, we set out to investigate factors associated with case fatality in Scotland.
Methods:
We included all episodes of iGAS notified in Scotland surveillance data from January 2017 to December 2024. Case fatality was ascertained by 7-day follow-up. Regression models incorporating key clinical, microbiological, and demographic predictors were constructed to investigate factors associated with higher case fatality.
Results:
There were 2209 iGAS notifications, of whom 191 died (8.6%). In multivariate analysis, increasing age (OR for 45-64 years: 2.36 [95% CI:1.3-4.48]; OR for 65-74 years: 4.54 [2.41-8.89]; and OR for 75 years and over: 7.77 [3.4-14.8]; emm type 3.93 (OR: 3.13 [1.43-6.76]) and emm type 1 (3.44 [2-6.15]); alcohol misuse (2.56 [1.36-4.63]); respiratory tract infection (2.07 [1.27-3.32]); and intensive care admission (2.5 [1.7-3.66]) were all significantly associated with mortality.
Conclusion:
Case fatality from iGAS was high, particularly for vulnerable populations, and for those with emm type 3.93 and emm type 1 infections. Novel clinical, therapeutic, and public health interventions to improve clinical outcomes are required.
More Related Videos
09:25Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:23Rheumatic Heart Disease I: Introduction
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:21Rheumatic Heart Disease III: Medical Management
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...